Table 3 Vit. D level change (difference Vit. D-w1–Vit. D-w4) during illness and IgG level change 3 months PSO (difference IgG-w4–IgG-m4).

From: Relationship of anti-SARS-CoV-2 IgG antibodies with Vitamin D and inflammatory markers in COVID-19 patients

 

Vitamin D change

IgG change

Difference

Vit. D-w1–Vit. D-w4

Statistics

Difference

IgG-w4–IgG-m4

Statistics

Frequency N (%)

Increase

17 (34.0)

 

11 (64.7)

 

Decrease

33 (66.0)

 

7 (35.3)

 

Sex N (mean rank)

  

U = 266, p = 0.372

 

U = 30, p = 0.763

F

26 (23.73)

 

11 (9.27)

 

M

24 (27.42)

 

6 (8.50)

 

Age N (mean rank)

  

H(5) = 6.027, p = 0.304

 

H(4) = 4.036, p = 0.401

0–29

 

5 (25.9)

 

4 (8.50)

 

30–39

 

3 (20.67)

 

3 (10.00)

 

40–49

 

4 (41.88)

 

3 (8.67)

 

50–59

 

10 (21.95)

 

3 (4.67)

 

60–69

 

14 (24.89)

 

4 (12.25)

 

70+

 

14 (24.86)

   

Disease severity N (mean rank)

  

H(3) = 0.542, p = 0.910

 

H(2) = 6.489, p = 0.039

Mild

 

8 (25.31)

 

8 (6.63)

 

Moderate

 

18 (24.00)

 

6 (9.00)

 

Severe

 

22 (26.30)

 

3 (15.33)

 

Critical

 

2 (31.00)

   

Hospitalisation N (mean rank)

  

U = 194.5, p = 0.309

 

U = 2, p = 0.017

No

13 (21.96)

 

14 (7.64)

 

Yes

37 (26.74)

 

3 (15.33)

 

Difference between medians N (mean rank)

  

Z = − 2.129, p = 0.033

 

Z = − 2.107, p = 0.035

Negative Ranks

33 (26.00)

 

11 (11.0)

 

Positive Ranks

17 (24.53)

 

6 (5.33)

 
  1. U Mann–Whitney U test, H Kruskal–Wallis test, Z Wilcoxon Signed Ranks test.